Modern Insulin, Device, and Technology: Tips For Clinicians

Abm Kamrul Hasan
{"title":"Modern Insulin, Device, and Technology: Tips For Clinicians","authors":"Abm Kamrul Hasan","doi":"10.3329/bjm.v34i20.66135","DOIUrl":null,"url":null,"abstract":"Insulin has been a lifesaving treatment for people with diabetes since its discovery in 1921. However, the way insulin is delivered evolved over time. Modern insulin, devices, and technology have transformed the management of diabetes and improved the quality of life for millions of people worldwide.Modern insulins are designed to match the needs of people with diabetes better. Traditional insulins, such as regular and NPH insulin, have a delayed onset and peak, making it difficult to manage blood sugar levels. Newer insulins, such as rapid-acting insulin analogs like aspart, glulisine, and lispro, have a faster onset and shorter duration of action, allowing for greater dosing and timing flexibility. Long-acting insulin analogs, like glargine and detemir, provide more consistent blood sugar control and less hypoglycemia risk.Insulin delivery devices have also advanced significantly. The most common device is the insulin pen, which looks like a large pen and uses disposable insulin cartridges. The pen has replaced traditional syringes and vials for many people with diabetes, offering greater convenience and ease of use. Insulin pumps are also becoming more popular, especially among people with type 1 diabetes. A pump delivers insulin through a catheter inserted under the skin, which can be programmed to provide a continuous infusion of insulin or a bolus dose before meals.Technological advancements have also revolutionized diabetes management. Continuous glucose monitoring (CGM) systems use a small sensor inserted under the skin to measure glucose levels every few minutes, providing real-time data to help people make more informed decisions about insulin dosing and food choices. Some CGM systems also offer alerts for high and low blood sugar levels, making it easier to avoid dangerous fluctuations. Automated insulin delivery systems, also known as closed-loop systems or artificial pancreas systems, use CGM data to automatically adjust insulin delivery, reducing the burden of constant monitoring and decision-making for people with diabetes.In summary, modern insulin, devices, and technology have greatly improved the management of diabetes, allowing for better blood sugar control and a better quality of life for people with diabetes. As technology continues to advance, the future of diabetes management looks promising.\nBangladesh J Medicine 2023; Vol. 34, No. 2(1) Supplement: 191","PeriodicalId":8721,"journal":{"name":"Bangladesh Journal of Veterinary Medicine","volume":"55 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangladesh Journal of Veterinary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/bjm.v34i20.66135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Insulin has been a lifesaving treatment for people with diabetes since its discovery in 1921. However, the way insulin is delivered evolved over time. Modern insulin, devices, and technology have transformed the management of diabetes and improved the quality of life for millions of people worldwide.Modern insulins are designed to match the needs of people with diabetes better. Traditional insulins, such as regular and NPH insulin, have a delayed onset and peak, making it difficult to manage blood sugar levels. Newer insulins, such as rapid-acting insulin analogs like aspart, glulisine, and lispro, have a faster onset and shorter duration of action, allowing for greater dosing and timing flexibility. Long-acting insulin analogs, like glargine and detemir, provide more consistent blood sugar control and less hypoglycemia risk.Insulin delivery devices have also advanced significantly. The most common device is the insulin pen, which looks like a large pen and uses disposable insulin cartridges. The pen has replaced traditional syringes and vials for many people with diabetes, offering greater convenience and ease of use. Insulin pumps are also becoming more popular, especially among people with type 1 diabetes. A pump delivers insulin through a catheter inserted under the skin, which can be programmed to provide a continuous infusion of insulin or a bolus dose before meals.Technological advancements have also revolutionized diabetes management. Continuous glucose monitoring (CGM) systems use a small sensor inserted under the skin to measure glucose levels every few minutes, providing real-time data to help people make more informed decisions about insulin dosing and food choices. Some CGM systems also offer alerts for high and low blood sugar levels, making it easier to avoid dangerous fluctuations. Automated insulin delivery systems, also known as closed-loop systems or artificial pancreas systems, use CGM data to automatically adjust insulin delivery, reducing the burden of constant monitoring and decision-making for people with diabetes.In summary, modern insulin, devices, and technology have greatly improved the management of diabetes, allowing for better blood sugar control and a better quality of life for people with diabetes. As technology continues to advance, the future of diabetes management looks promising. Bangladesh J Medicine 2023; Vol. 34, No. 2(1) Supplement: 191
现代胰岛素,设备和技术:给临床医生的提示
自1921年发现胰岛素以来,它一直是糖尿病患者的救命良药。然而,胰岛素的输送方式随着时间的推移而进化。现代胰岛素、设备和技术已经改变了糖尿病的管理,改善了全世界数百万人的生活质量。现代胰岛素的设计是为了更好地满足糖尿病患者的需要。传统的胰岛素,如常规胰岛素和NPH胰岛素,起效较晚,达到峰值,因此很难控制血糖水平。较新的胰岛素,如速效胰岛素类似物,如天冬氨酸、葡氨酸和利斯普罗,起效更快,作用时间更短,允许更大的剂量和时间灵活性。长效胰岛素类似物,如甘精氨酸和地特米,提供更稳定的血糖控制和更低的低血糖风险。胰岛素输送装置也有了显著的进步。最常见的设备是胰岛素笔,它看起来像一支大笔,使用一次性胰岛素盒。对于许多糖尿病患者来说,这种笔已经取代了传统的注射器和小瓶,提供了更大的方便和易用性。胰岛素泵也越来越受欢迎,尤其是在1型糖尿病患者中。胰岛素泵通过插入皮下的导管输送胰岛素,该导管可被设定为连续输注胰岛素或饭前注射胰岛素。技术进步也使糖尿病的管理发生了革命性的变化。连续血糖监测(CGM)系统使用一个插入皮下的小传感器,每隔几分钟测量一次血糖水平,提供实时数据,帮助人们在胰岛素剂量和食物选择方面做出更明智的决定。一些CGM系统还提供高血糖和低血糖警报,使其更容易避免危险的波动。自动胰岛素输送系统,也被称为闭环系统或人工胰腺系统,使用CGM数据自动调整胰岛素输送,减轻糖尿病患者持续监测和决策的负担。总之,现代胰岛素、设备和技术极大地改善了糖尿病的管理,使糖尿病患者能够更好地控制血糖,提高生活质量。随着技术的不断进步,糖尿病管理的未来看起来很有希望。孟加拉国J医学2023;第34卷,第2(1)号补编:191
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信